| Literature DB >> 28567199 |
Wongani Js Nyangulu1, Edson Mwinjiwa1, Titus H Divala2, Randy G Mungwira2, Osward Nyirenda2, Maxwell Kanjala2, Gillian Mbambo3, Jane Mallewa4, Terrie E Taylor2, Matthew B Laurens3, Miriam K Laufer3, Joep J van Oosterhout1,4.
Abstract
We describe two Malawian adults on successful antiretroviral therapy who experienced frequent malaria episodes after stopping cotrimoxazole prophylaxis. We argue that, in addition to stopping cotrimoxazole, diminished malaria immunity and drug interactions between efavirenz and artemether-lumefantrine may have played a causative role in the recurrent malaria our patients experienced.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28567199 PMCID: PMC5442494 DOI: 10.4314/mmj.v29i1.12
Source DB: PubMed Journal: Malawi Med J ISSN: 1995-7262 Impact factor: 0.875